Stock Ticker

  • Loading stock data...

pSivida Corp. (NASDAQ:PSDV) Elects Veteran Healthcare Executive To Its Board

pSivida Corp. (NASDAQ:PSDV) reported that it has elected Kristine Peterson, who is a seasoned healthcare executive, to its Board of Directors. Peterson has extensive pharma experience, having worked as the CEO of Valeritas from 2009 to 2016, a commercial-stage medical technology firm focused on simplifying life and improving health for people with diabetes. She has […]

Johnson & Johnson (NYSE:JNJ)’s New Drug Cures 80% Of Hepatitis C Patients

Boston, MA 10/24/2013 (wallstreetpr) – A new drug from Johnson & Johnson (NYSE:JNJ) is expected to cure 80% of hepatitis C patients. The current line of treatment has been developed 20 years ago and lasts for one year with regular regimen of pills and injections. The cure rate is only 50% and also has adverse side effects […]

Johnson & Johnson (NYSE:JNJ) Results Exceed Predictions

Boston, MA 10/16/2013 (wallstreetpr) – Third-quarter results of pharmaceutical giant Johnson & Johnson (NYSE:JNJ) have beaten expectations. Johnson & Johnson on Tuesday declared that it had clocked about $2.98 billion in net earnings or $1.04 per share for the third quarter as compared to $2.97 billion or $1.05 per share a year ago. JOHNSON & JOHNSON’s per-share […]

Major Drug Makers; Johnson & Johnson (JNJ) and Eli Lilly (LLY) Database Collaboration – JNJ, PFE, BMY, MRK, ABT

On Monday, current three major drug makers Eli Lilly & Co. (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), and Merck & Co., Inc. (NYSE:MRK) have decided to collaborate on a database that will assist speed up the investigational drug testing process. The firm will each contribute to a database, which will be made of doctors, hospitals and […]

Quest Diagnostics (NYSE:DGX) Announce Quarter Dividend and Cost Cut Plan – DGX, DVAX, PFE, JNJ, BMY

Quest Diagnostics Inc (NYSE:DGX) announced on Friday that it is surging its quarterly dividend by 76 percent to 30 cents per share. It will be paid on Jan. 28. The firm reported that it aims to cut costs by $500M in 2014. It will go out 2014 with a run-rate savings of $600M, increase from […]

Titan Pharmaceuticals Falls Through the Floor (TTNP)

Titan Pharmaceuticals (OTC: TTNP) released second quarter results this morning that showed revenues doubling to $1.4 million from the same period in 2011. The top line consisted of royalties on the net sales of Fanapt. Operating expenses in the quarter decreased by 36% from one year ago. For the quarter, the company reported a net of […]

Medicare Coverage Heals A Painful Summer For Cytomedix (CMXI)

A dismal summer for Cytomedix (OTC: CMXI) stock suddenly turned a little brighter today. The Centers for Medicare and Medicaid Services announced that they had approved coverage for autologous blood-derived products (the patient’s own blood) used in the treatment of chronic wounds specifically resulting from diabetes and pressure or venous wounds. Cytomedix develops and sells regenerative therapies including […]

Sign Up To Get Our Latest Stocks Alerts